Induction of apoptosis by plumbagin through reactive oxygen species-mediated inhibition of topoisomerase II A Kawiak, J Piosik, G Stasilojc, A Gwizdek-Wisniewska, L Marczak, ... Toxicology and Applied Pharmacology 223 (3), 267-276, 2007 | 115 | 2007 |
Induction of Apoptosis in HL-60 Cells through the ROS-Mediated Mitochondrial Pathway by Ramentaceone from Drosera aliciae A Kawiak, J Zawacka-Pankau, A Wasilewska, G Stasilojc, J Bigda, ... Journal of Natural Products 75 (1), 9-14, 2012 | 62 | 2012 |
Specific Activation of A3, A2A and A1 Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and … P Koszałka, M Gołuńska, A Urban, G Stasiłojć, M Stanisławowski, ... PloS one 11 (3), e0151420, 2016 | 56 | 2016 |
Inhibition of CD73 stimulates the migration and invasion of B16F10 melanoma cells in vitro, but results in impaired angiogenesis and reduced melanoma growth in vivo P Koszałka, A Pryszlak, M Gołuńska, J Kolasa, G Stasiłojć, ... Oncology reports 31 (2), 819-827, 2014 | 44 | 2014 |
MiR-192 and miR-662 enhance chemoresistance and invasiveness of squamous cell lung carcinoma M Filipska, M Skrzypski, K Czetyrbok, T Stokowy, G Stasiłojć, A Supernat, ... Lung Cancer 118, 111-118, 2018 | 41 | 2018 |
CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis P Koszałka, M Gołuńska, M Stanisławowski, A Urban, G Stasiłojć, ... The international journal of biochemistry & cell biology 69, 1-10, 2015 | 40 | 2015 |
Testing the activity of complement convertases in serum/plasma for diagnosis of C4NeF-mediated C3 glomerulonephritis AM Blom, F Corvillo, M Magda, G Stasiłojć, P Nozal, MÁ Pérez-Valdivia, ... Journal of clinical immunology 36, 517-527, 2016 | 35 | 2016 |
The designer drug 3-fluoromethcathinone induces oxidative stress and activates autophagy in HT22 neuronal cells K Siedlecka-Kroplewska, A Wrońska, G Stasiłojć, Z Kmieć Neurotoxicity research 34, 388-400, 2018 | 28 | 2018 |
New perspectives on complement mediated immunotherapy G Stasiłojć, A Österborg, AM Blom, M Okrój Cancer Treatment Reviews 45, 68-75, 2016 | 21 | 2016 |
Novel 5-Substituted 2-(Aylmethylthio)-4-chloro-N-(5-aryl-1,2,4-triazin-3-yl)benzenesulfonamides: Synthesis, Molecular Structure, Anticancer Activity, Apoptosis … B Żołnowska, J Sławiński, A Pogorzelska, K Szafrański, A Kawiak, ... Molecules 21 (6), 808, 2016 | 20 | 2016 |
Gain-of-function mutation in complement C2 protein identified in a patient with aHUS A Urban, E Volokhina, A Felberg, G Stasiłojć, AM Blom, I Jongerius, ... Journal of Allergy and Clinical Immunology 146 (4), 916-919. e11, 2020 | 15 | 2020 |
Gain of function mutant of complement factor B K323E mimics pathogenic C3NeF autoantibodies in convertase assays A Urban, A Borowska, A Felberg, L van den Heuvel, G Stasiłojć, ... Autoimmunity 51 (1), 18-24, 2018 | 14 | 2018 |
Gain-of-function mutations R249C and S250C in complement C2 protein increase C3 deposition in the presence of C-reactive protein A Urban, D Kowalska, G Stasiłojć, A Kuźniewska, A Skrobińska, E Arjona, ... Frontiers in immunology 12, 724361, 2021 | 13 | 2021 |
Monitoring of the complement system status in patients with B-cell malignancies treated with rituximab A Felberg, M Taszner, A Urban, A Majeranowski, K Jaskuła, A Jurkiewicz, ... Frontiers in Immunology 11, 584509, 2020 | 13 | 2020 |
Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics A Felberg, A Urban, A Borowska, G Stasiłojć, M Taszner, A Hellmann, ... Cancer Immunology, Immunotherapy 68, 587-598, 2019 | 11 | 2019 |
Synthesis, QSAR studies, and metabolic stability of novel 2‐alkylthio‐4‐chloro‐N‐(5‐oxo‐4,5‐dihydro‐1,2,4‐triazin‐3‐yl)benzenesulfonamide derivatives as … B Żołnowska, J Sławiński, A Pogorzelska, K Szafrański, A Kawiak, ... Chemical Biology & Drug Design 90 (3), 380-396, 2017 | 10 | 2017 |
Clinical and Biological Significance of ESR1 Gene Alteration and Estrogen Receptors Isoforms Expression in Breast Cancer Patients A Nagel, J Szade, M Iliszko, J Elzanowska, M Welnicka-Jaskiewicz, ... International Journal of Molecular Sciences 20 (8), 1881, 2019 | 9 | 2019 |
Calcein release assay as a method for monitoring serum complement activity during monoclonal antibody therapy in patients with B-cell malignancies G Stasiłojć, A Felberg, A Urban, D Kowalska, S Ma, AM Blom, J Lundin, ... Journal of immunological methods 476, 112675, 2020 | 8 | 2020 |
Defective apoptosis of U937 cells induced by benzyl isothiocyanate (BITC) G Stasiłojć, A Nagel, P Koszałka, JJ Bigda Acta Biochimica Polonica 66 (4), 401-407, 2019 | 8 | 2019 |
Synthesis, molecular structure, and metabolic stability of new series of N'-(2-alkylthio-4-chloro-5-methylbenzenesulfonyl)-1-(5-phenyl-1H-pyrazol-1-yl) amidine as potential … A Pogorzelska, J Sławiński, A Kawiak, B Żołnowska, J Chojnacki, ... European Journal of Medicinal Chemistry 155, 670-680, 2018 | 8 | 2018 |